Cargando…

A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test

The qualitative ID Now COVID-19 assay combines claimed performance and ease of use that seem to position it as a reliable test for urgent patient management. However, the declared limit of detection (LOD) of 125 genome equivalents/mL is not confirmed by the published studies, which observed a range...

Descripción completa

Detalles Bibliográficos
Autores principales: Aupaix, Antoine, Lazarova, Elena, Chemais, Monia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452348/
https://www.ncbi.nlm.nih.gov/pubmed/34555430
http://dx.doi.org/10.1016/j.jviromet.2021.114293